Page last updated: 2024-09-05

lu 135252 and Disease Exacerbation

lu 135252 has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, T; Liu, J; Sai, X; Sun, Y; Wang, D; Yang, B; Zhou, R1
Arck, PC; Godes, M; Herzfeld, S; Hocher, B; Kalk, P; Mach, A; Nafz, B; Neumayer, HH; Slowinski, T; Wiesner, D1
Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Jougasaki, M; Lisy, O; Schirger, JA1
Brochu, E; Grose, JH; Kingma, I; Lacasse, S; Larivière, R; Lebel, M; Moreau, C1

Other Studies

4 other study(ies) available for lu 135252 and Disease Exacerbation

ArticleYear
Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:6

    Topics: Animals; Aorta, Abdominal; Atherosclerosis; Atorvastatin; Diet, High-Fat; Disease Models, Animal; Disease Progression; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Endothelin-1; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iliac Artery; Inflammation Mediators; Lipids; Male; Matrix Metalloproteinase 9; NF-kappa B; Phenylpropionates; Plaque, Atherosclerotic; Pyrimidines; Pyrroles; Rabbits; RNA, Messenger

2014
ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
    Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:2

    Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Fibrosis; Kidney; Kidney Tubules; Male; Organ Size; Phenylpropionates; Polycystic Kidney Diseases; Propionates; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Circulation

2003
Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
    Circulation, 2004, Jan-20, Volume: 109, Issue:2

    Topics: Animals; Disease Progression; Dogs; Endothelin A Receptor Antagonists; Endothelin-1; Heart Failure; Hemodynamics; Kidney; Male; Phenylpropionates; Pyrimidines; Renin; Renin-Angiotensin System; Sodium

2004
Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:8

    Topics: Animals; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Kidney Failure, Chronic; Male; Osmolar Concentration; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Uremia

1999